Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04289311 · ClinicalTrials.gov registry record · NA

SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT04289311 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04289311, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to find out whether a web-based intervention using a mobile device is helpful for teens learning to care for and manage symptoms of sickle cell disease. The intervention lasts 12 weeks with a 3-month follow up period, and uses a smartphone or a tablet.

Interventions

  • BEHAVIORAL Voice Crisis Alert V2

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-07-13
Est. Completion 2021-12-17
Phase NA

What the Registry Record Tells You About NCT04289311

The ClinicalTrials.gov registry entry for NCT04289311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Voice Crisis Alert V2 is the first listed.

NCT04289311 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04289311 about?

NCT04289311 is a clinical study titled "SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease". The purpose of this study is to find out whether a web-based intervention using a mobile device is helpful for teens learning to care for and manage symptoms of sickle cell disease. The intervention lasts 12 weeks with a 3-month follow up period, and uses a smartphone or a tablet.

What is the current status of trial NCT04289311?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-07-13. Estimated completion is 2021-12-17.

What interventions are being tested in trial NCT04289311?

The interventions under investigation include: Voice Crisis Alert V2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT04289311?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.